1. Home
  2. IBRX vs OMF Comparison

IBRX vs OMF Comparison

Compare IBRX & OMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$9.17

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Logo OneMain Holdings Inc.

OMF

OneMain Holdings Inc.

HOLD

Current Price

$60.45

Market Cap

6.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
OMF
Founded
2014
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.6B
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
IBRX
OMF
Price
$9.17
$60.45
Analyst Decision
Strong Buy
Buy
Analyst Count
7
12
Target Price
$12.57
$66.75
AVG Volume (30 Days)
11.7M
968.7K
Earning Date
05-08-2026
05-01-2026
Dividend Yield
N/A
7.25%
EPS Growth
38.71
54.72
EPS
N/A
1.93
Revenue
$113,288,000.00
N/A
Revenue This Year
$88.59
$66.43
Revenue Next Year
$131.15
$6.97
P/E Ratio
N/A
$31.28
Revenue Growth
668.31
N/A
52 Week Low
$1.95
$45.78
52 Week High
$12.43
$71.93

Technical Indicators

Market Signals
Indicator
IBRX
OMF
Relative Strength Index (RSI) 70.92 63.09
Support Level $6.69 $55.93
Resistance Level $9.54 $61.16
Average True Range (ATR) 0.55 1.51
MACD 0.23 0.39
Stochastic Oscillator 90.94 74.37

Price Performance

Historical Comparison
IBRX
OMF

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About OMF OneMain Holdings Inc.

OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company operates in single reportable segment Consumer and Insurance which originates and services personal loans and auto finance loans, offer credit cards, and provide optional credit and non-credit insurance and other optional products through its branch and central operations, as well as digital platform.

Share on Social Networks: